
|Articles|August 1, 2003
Supplements and Featured Publications
- Examining the Dyslipidemia Constellation
- Volume 9
- Issue 1 Dyslipid
Inflammatory markers are useful risk assessment tools
Author(s)Peter Libby, MD
Advertisement
Articles in this issue
over 22 years ago
NCEP ATP III guidelines incorporate global risk assessmentover 22 years ago
Case reports illustrate consequences of ATP III in practiceover 22 years ago
IVUS is redefining atherosclerotic diseaseNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Government Shutdown Concluded but ACA Subsidies in Limbo
2
5 AI and Digital Health Advances Transforming Breast Cancer Care and Research
3
CD19 CAR T-Cell Therapy Shows Promising Activity in Richter Transformation
4
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
5















































